DiaSorin S.p.A.
DIA
Peringkat dalam Saham
#3798
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Harga Saham
$88.31
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$4.37B
Perubahan (1 hari)
-6.35%
Perubahan (1 tahun)
-2.42%
Negara
IT
Perdagangan DiaSorin S.p.A. (DIA)
Kategori
Healthcare
Jumlah saham beredar untuk DiaSorin S.p.A. (DIA)
Jumlah saham beredar per October 2026: 0
Menurut laporan keuangan terbaru dan harga saham DiaSorin S.p.A., jumlah saham beredar saat ini adalah 0. Pada akhir October 2026, perusahaan memiliki 0 saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk DiaSorin S.p.A. (DIA) dari 2026 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 371.00M | - |
US
|
|
| 705.30M | - |
US
|
|
| 143.28M | - |
US
|
|
| - | - |
CN
|
|
| 282.00M | - |
US
|
